 The world is experiencing a shift towards an older population, which has led to a reduction in the burden of chronic diseases in younger adults. However, there is little evidence to suggest that this improvement extends to older adults. Statins have the potential to reduce the risk of various causes of disability in older age, including major cardiovascular disease. A randomized controlled trial is being conducted to examine whether statins can help prevent or delay the onset of such conditions in older adults who do not have any existing cardiovascular disease, diabetes, or dementia. The study will involve participants aged 70 years and above, who will be randomly assigned to either receive at or the state in, a type of statin, or a placebo. The primary outcome measures include disability-free survival, defined as survival-free from dementia and persistent physical disability, and major cardiovascular events, such as cardiovascular death, non-fatal myocardial infarction, or stroke. Secondary outcomes include all-cause mortality, dementia, and other cognitive decline, persistent physical disability, fatal and non. This article was authored by Rory Wolfe, Christopher M. Reed, Andrew Tonkin, and others. We are article.tv, links in the description below.